These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3717192)

  • 1. In vitro considerations in monotherapy and combination therapy for severe infections.
    Gaya H
    Am J Med; 1986 May; 80(5C):75-8. PubMed ID: 3717192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibacterial agents: the role of new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
    Klastersky J
    Clin Haematol; 1984 Oct; 13(3):587-98. PubMed ID: 6388934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
    Klastersky J
    Schweiz Med Wochenschr Suppl; 1983; 14():64-9. PubMed ID: 6361994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concept of empiric therapy with antibiotic combinations. Indications and limits.
    Klastersky J
    Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host.
    Gaya H
    Am J Med; 1986 Jun; 80(6B):149-55. PubMed ID: 3728525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic therapy for severe gram-negative infections].
    Vildé JL; Leport C
    Rev Prat; 1983 Jan; 33(3):117-24. PubMed ID: 6844820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic combination therapy and chemotherapeutic prophylaxis].
    Noseda G
    Schweiz Med Wochenschr; 1975 Mar; 105(9):272-7. PubMed ID: 1124386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
    Gaya H
    Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro models in the study of antibiotic therapy of infections in neutropenic patients.
    Zinner SH; Blaser J
    Am J Med; 1986 May; 80(5C):40-4. PubMed ID: 3717188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
    Gaya H
    Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients.
    Zinner SH; Blaser J; Gaya H
    Am J Med; 1986 May; 80(5C):59-63. PubMed ID: 3717189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
    Cortelezzi A; Radaelli F; Penagini R; Pogliani EM
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):520-3. PubMed ID: 6983502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
    Hammerstrøm J; Jacobsen T
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.